BioVie (BIVI) Earnings Date & Reports

BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

BIVI is expected to report earnings to fall 25.00% to -15 cents per share on August 28

Q2'24

Est.

$-0.15

Q1'24

Est.

$-0.20

Q4'23

Est.

$-0.23

Q3'23

Est.

$-0.29

Q2'23

Est.

$-0.25

The last earnings report on May 10 showed earnings per share of -20 cents, meeting the estimate of -20 cents. With 305.53K shares outstanding, the current market capitalization sits at 20.11M.

View a ticker or compare two or three

Compare

BIVI